Kestra Medical Technologies (KMTS) Total Non-Current Liabilities (2024 - 2026)
Kestra Medical Technologies (KMTS) posted quarterly Total Non-Current Liabilities of $98.5 million for Q2 2026, up 19.77% year-over-year from $82.2 million in Q2 2025, and up 7.99% quarter-over-quarter from $91.2 million in Q1 2026.
Kestra Medical Technologies (KMTS) Total Non-Current Liabilities (2024 - 2026) Analysis & Trends
Kestra Medical Technologies (KMTS) has reported Total Non-Current Liabilities for 3 consecutive years, with $98.5 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Non-Current Liabilities rose 19.77% year-over-year to $98.5 million; the TTM figure through Apr 2026 stood at $98.5 million (up 19.77% YoY), while the FY2026 annual figure was $98.5 million, up 19.77% from the prior year.
- Total Non-Current Liabilities advanced to $98.5 million in Q2 2026 per KMTS's latest filing, from $91.2 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $98.5 million in Q2 2026 and bottomed at $78.1 million in Q2 2024.
- Historically, Total Non-Current Liabilities has averaged $85.7 million across 3 years, with a median of $82.5 million in 2025.
- Annual changes were most pronounced in 2025 — Total Non-Current Liabilities increased 5.25% — and 2026, when it grew 19.77%.
- Kestra Medical Technologies' Total Non-Current Liabilities stood at $78.1 million in 2024, then climbed by 5.55% to $82.5 million in 2025, then increased by 19.42% to $98.5 million in 2026.
- Business Quant data shows KMTS's Total Non-Current Liabilities at $98.5 million in Q2 2026, $91.2 million in Q1 2026, and $82.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.69 Bn | 129.47 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.58 Bn | 51.71 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.75 Bn | 34.39 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.89 Bn | 32.42 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 29.13 Bn | 26.45 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 24.97 Bn | 24.53 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.40 Bn | 14.99 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.84 Bn | 14.70 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.61 Bn | 11.46 Bn | 1.03 Bn | 12.41 Bn |
| 10 | Kestra Medical Technologies | 1.46 Bn | 1.10 Bn | 15.68 Mn | 97.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 98.50 Mn |
| Jan 31, 2026 | 91.21 Mn |
| Oct 31, 2025 | 82.48 Mn |
| Jul 31, 2025 | 82.00 Mn |
| Apr 30, 2025 | 82.24 Mn |
| Jan 31, 2025 | 85.30 Mn |
| Apr 30, 2024 | 78.14 Mn |